PMID- 35573863
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 1178-7007 (Print)
IS  - 1178-7007 (Electronic)
IS  - 1178-7007 (Linking)
VI  - 15
DP  - 2022
TI  - Association of the Coronavirus Disease 2019 Outbreak on the Diabetes 
      Self-Management in Chinese Patients: An Analytical Cross-Sectional Study.
PG  - 1413-1422
LID - 10.2147/DMSO.S351823 [doi]
AB  - BACKGROUND: The coronavirus disease 2019 (COVID-19) outbreak has seriously 
      affected people's lives, especially those with chronic diseases. Diabetes 
      self-management, which plays an important role in glycaemic control and reducing 
      the risk of acute and long-term complications, may be discouraged by social 
      distancing. PURPOSE: To evaluate the level of self-management activities in 
      Chinese patients with type 2 diabetes mellitus (T2DM) during the COVID-19 
      pandemic. PATIENTS AND METHODS: A survey of with 872 patients with T2DM in the 
      inpatient and outpatient departments through face-to-face interviews was 
      conducted from 1 July, 2020 to 30 September, 2020. The main outcome measures were 
      glycaemic control status and level of self-management activities during the 
      pandemic. RESULTS: In terms of glycaemic control, the data showed that patients 
      with fasting plasma glucose (FPG) < 7.0 mmol/L (36.4%), postprandial plasma 
      glucose (PPG) < 10.0 mmol/L (26.3%), or glycosylated haemoglobin (HbA1c) < 7.0% 
      (18.6%) in our investigation has well-controlled blood glucose level, and 11.9% 
      of patients experienced blood glucose <3.9 mmol/L during the outbreak. The 
      diabetes self-management of Chinese patients decreased and the final diabetes 
      self-management score of the Chinese patients was 3.4 +/- 1.45. Patients with 
      higher education, diabetes education, comorbidities, and online consultations had 
      higher diabetes self-management scores (P <0.05). Adherence to diabetes 
      self-management in the normal glycaemic control group was higher than that in the 
      substandard glycaemic control group (P<0.05). Among all participants, 72.1% of 
      the patients reduced the frequency of hospital visits, and 44.8% considered that 
      they had diabetes-related stress during the pandemic. The mean anxiety level 
      score rated by 286 patients was 5.3+/-2.8. CONCLUSION: The COVID-19 pandemic has 
      affected diabetes self-management, including substandard glycemic control, 
      increased diabetes-related stress, limited exercise range and medical visits. 
      Therefore, future interventions should focus on the online management of chronic 
      diseases and support online consultation' development and promotion, which can 
      overcome physical distance and provide personalized services conveniently.
CI  - (c) 2022 Huang et al.
FAU - Huang, Linyan
AU  - Huang L
AD  - Department of Endocrinology, Zhujiang Hospital, Southern Medical University, 
      Guangzhou, People's Republic of China.
FAU - Zhang, Li
AU  - Zhang L
AD  - Department of Endocrinology, Zhujiang Hospital, Southern Medical University, 
      Guangzhou, People's Republic of China.
AD  - Department of Endocrinology, People's Hospital of Dehong, Yunnan, People's 
      Republic of China.
FAU - Jiang, Shuiping
AU  - Jiang S
AD  - Department of Endocrinology, Zhujiang Hospital, Southern Medical University, 
      Guangzhou, People's Republic of China.
FAU - Liang, Baozhu
AU  - Liang B
AD  - Department of Endocrinology, Zhujiang Hospital, Southern Medical University, 
      Guangzhou, People's Republic of China.
FAU - Xu, Ningning
AU  - Xu N
AD  - Department of Endocrinology, Zhujiang Hospital, Southern Medical University, 
      Guangzhou, People's Republic of China.
FAU - Li, Jingxin
AU  - Li J
AD  - Department of Endocrinology, Zhujiang Hospital, Southern Medical University, 
      Guangzhou, People's Republic of China.
FAU - Zhang, Xiaoyan
AU  - Zhang X
AD  - Department of Endocrinology, Zhujiang Hospital, Southern Medical University, 
      Guangzhou, People's Republic of China.
AD  - Department of Pediatrics, Guangdong Provincial People's Hospital, Guangdong 
      Academy of Medical Sciences, Guangzhou, People's Republic of China.
FAU - Zhang, Zhen
AU  - Zhang Z
AD  - Department of Endocrinology, Zhujiang Hospital, Southern Medical University, 
      Guangzhou, People's Republic of China.
LA  - eng
PT  - Journal Article
DEP - 20220506
PL  - New Zealand
TA  - Diabetes Metab Syndr Obes
JT  - Diabetes, metabolic syndrome and obesity : targets and therapy
JID - 101515585
PMC - PMC9094639
OTO - NOTNLM
OT  - coronavirus disease 2019
OT  - diabetes self-management
OT  - online consultation
OT  - type 2 diabetes mellitus
COIS- The authors report no conflicts of interest in this work.
EDAT- 2022/05/17 06:00
MHDA- 2022/05/17 06:01
PMCR- 2022/05/06
CRDT- 2022/05/16 04:33
PHST- 2022/02/08 00:00 [received]
PHST- 2022/04/20 00:00 [accepted]
PHST- 2022/05/16 04:33 [entrez]
PHST- 2022/05/17 06:00 [pubmed]
PHST- 2022/05/17 06:01 [medline]
PHST- 2022/05/06 00:00 [pmc-release]
AID - 351823 [pii]
AID - 10.2147/DMSO.S351823 [doi]
PST - epublish
SO  - Diabetes Metab Syndr Obes. 2022 May 6;15:1413-1422. doi: 10.2147/DMSO.S351823. 
      eCollection 2022.